Market Chatter: Merck to Pay Over $50 Million to Settle More Than 200 Gardasil Cases

MT Newswires Live06-05 01:07

Merck (MRK) said Thursday it will pay over $50 million to settle more than 200 lawsuits that blame the drugmaker's Gardasil cancer vaccine for causing autoimmune ailments in young women, Bloomberg reported, citing an emailed statement from the company.

Gardasil prevents human papillomavirus infections. The lawsuits allege it can cause autoimmune conditions affecting the heart and reproductive systems in young women, according to the report.

Merck didn't immediately reply to a request for comment from MT Newswires.

Price: 119.28, Change: +4.58, Percent Change: +3.99

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment